Optiray and depressed level of consciousness Patient Reports February 10, 2012

Optiray Side Effects Report #5780049-7
Optiray side effect was reported by a Health Professional from JAPAN on June 11, 2008. Female patient was diagnosed with scan brain, diabetes mellitus and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, dyspnoea, laryngeal oedema. Optiray dosage: 100 ML, SINGLE. During the same period patient was treated with INSULIN ASPART. Patient recovered.

Optiray Side Effects Report #6134667-7
Optiray side effect was reported by a Physician from JAPAN on Mar 18, 2009. Male patient, 61 years of age, was diagnosed with computerised tomogram thorax and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, wheezing. Optiray dosage: 100 ML, SINGLE. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5097548-6
Optiray side effect was reported by a Physician from JAPAN on Aug 22, 2006. Female patient, 69 years of age, was diagnosed with computerised tomogram head and was treated with Optiray. After drug was administered, patient experienced the following side effects: chills, depressed level of consciousness, headache , nausea , oxygen saturation decreased, procedural complication, shock. Optiray dosage: 95 ML SINGLE INTRAVENOUS. During the same period patient was treated with METHYCOBAL, CEPHADOL. Patient recovered.

Optiray Side Effects Report #5003422-3
Optiray side effect was reported by a Physician from JAPAN on Apr 28, 2006. Female patient, 69 years of age, was diagnosed with computerised tomogram head and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, chills, depressed level of consciousness, headache , heart rate increased, malaise, nausea , oxygen saturation decreased. Optiray dosage: 95 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with MECOBALAMIN, DIFENIDOL HYDROCHLORIDE. Patient recovered.


Optiray Side Effects Report #5060267-6
Optiray side effect was reported by a Physician from JAPAN on July 14, 2006. Female patient, 86 years of age, was diagnosed with computerised tomogram abdomen and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, contrast media reaction, depressed level of consciousness, rash , shock, sneezing. Optiray dosage: 70 ML, SINGLE, INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #5201830-9
Optiray side effect was reported by a Physician from JAPAN on Dec 22, 2006. Female patient, 85 years of age, was diagnosed with computerised tomogram abdomen and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, incontinence, nausea , pulse absent, shock. Optiray dosage: 85 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with ORCIPRENALINE, AMLODIPIN, NICERGLINE, ALFACALCIDOL, FAMOTIDINE, VALSARTAN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5196226-2
Optiray side effect was reported by a Physician from JAPAN on Dec 12, 2006. Female patient, 85 years of age, was diagnosed with computerised tomogram abdomen and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, incontinence, shock. Optiray dosage: 85 ML, SINGLE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5266675-2
Optiray side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, 72 years of age, weighting 105.8 lb, was diagnosed with computerised tomogram abdomen and was treated with Optiray. After drug was administered, patient experienced the following side effects: arteriospasm coronary, bradycardia, convulsion, depressed level of consciousness, flushing, hypersensitivity, shock. Optiray dosage: 100 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with ISOSORBIDE DINITRATE, HEPARIN. Patient recovered.

Optiray Side Effects Report #5024989-5
Optiray side effect was reported by a Physician from JAPAN on May 26, 2006. Female patient, 86 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, rash , shock, sneezing. Optiray dosage: 70 ML, SINGLE, INTRAVENOUS. Patient recovered.


Optiray Side Effects Report #4659380-4
Optiray side effect was reported by a Physician from on Apr 26, 2005. Male patient, 82 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: brain oedema, cardio-respiratory arrest, depressed level of consciousness, hypoxic encephalopathy, nervous system disorder, procedural complication. Optiray dosage: 60 ML , ONCE. Patient died on 03/31/2005.

Optiray Side Effects Report #4886055-9
Optiray side effect was reported by a Physician from JAPAN on Jan 06, 2006. Male patient, 80 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: cyanosis, depressed level of consciousness, hypotension, nausea , pharyngeal oedema, procedural complication, respiratory arrest, skin discolouration. Optiray dosage: 100ML ONCE IV. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5069035-2
Optiray side effect was reported by a Physician from JAPAN on July 19, 2006. Female patient, 75 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, contrast media reaction, depressed level of consciousness, feeling cold, shock, wheezing. Optiray dosage: 100 ML, SINGLE, INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #5076074-4
Optiray side effect was reported by a Physician from JAPAN on July 27, 2006. Female patient, 75 years of age, weighting 90.39 lb, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, contrast media reaction, depressed level of consciousness, feeling cold, respiratory arrest, shock, wheezing. Optiray dosage: unknown. During the same period patient was treated with FERROMIA, NIVADIL, MUCOSTA, RABEPRAZOLE, URSENNID, SOLDEM, RADICUT, ASCORBIC ACID. Patient recovered.

Optiray Side Effects Report #5089478-0
Optiray side effect was reported by a Physician from JAPAN on Aug 10, 2006. Female patient, 75 years of age, weighting 90.39 lb, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, feeling cold, respiratory arrest, shock, wheezing. Optiray dosage: 100 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with FERROMIA, NIVADIL, MUCOSTA, RABEPRAZOLE, PURSENNID, SOLDEM, RADICUT, ASCORBIC ACID. Patient recovered.


Optiray Side Effects Report #5094420-2
Optiray side effect was reported by a Physician from JAPAN on Aug 18, 2006. Male patient, 72 years of age, weighting 121.7 lb, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, cold sweat, depressed level of consciousness, feeling hot, oxygen saturation decreased, peripheral coldness, sneezing. Optiray dosage: 100 ML, SINGLE, INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #4956228-5
Optiray side effect was reported by a Physician from JAPAN on Mar 16, 2006. Male patient, 72 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, cardio-respiratory arrest, depressed level of consciousness. Optiray dosage: 100 ML, ONCE. During the same period patient was treated with MIXED AMINO ACID, MEROPENEM TRIHYDRATE. Patient recovered.

Optiray Side Effects Report #4692314-5
Optiray side effect was reported by a Pharmacist from on June 03, 2005. Female patient, 70 years of age, weighting 45.00 lb, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: depressed level of consciousness, respiratory depression, shock. Optiray dosage: unknown. During the same period patient was treated with BERAPROST, TEPRENONE, DILTIAZEM HYDROCHLORIDE, CLINIDIPINE, ISOSORBIDE DINITRATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #4701412-9
Optiray side effect was reported by a Pharmacist from on June 14, 2005. Female patient, 70 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: abdominal pain , anaphylactic shock, blood pressure decreased, contrast media reaction, cyanosis, depressed level of consciousness, feeling abnormal, metabolic acidosis, nausea . Optiray dosage: unknown. During the same period patient was treated with BERAPROST, TEPRENONE, DILTIAZEM HYDROCHLORIDE, CLINIDIPINE, ISOSORBIDE DINITRATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #4991190-0
Optiray side effect was reported by a Physician from JAPAN on Apr 18, 2006. Male patient, 67 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, aphasia , blood pressure decreased, blood pressure systolic increased, contrast media reaction, depressed level of consciousness, dyspnoea, fall , hyperhidrosis. Optiray dosage: 95 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, PICOSULPHATE. Patient was hospitalized. Patient recovered.


Optiray Side Effects Report #4998518-6
Optiray side effect was reported by a Physician from JAPAN on Apr 25, 2006. Male patient, 67 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, aphasia , depressed level of consciousness, fall , laryngeal oedema. Optiray dosage: 95 ML SINGLE INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, PICOSULPHATE. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5006960-2
Optiray side effect was reported by a Physician from JAPAN on Apr 25, 2006. Male patient, 67 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, aphasia , depressed level of consciousness, fall , laryngeal oedema, pulse absent. Optiray dosage: 95 ML, SINGLE, INTRAVENOUS. During the same period patient was treated with AMLODIPINE BESYLATE, PICOSULPHATE. Patient was hospitalized. Patient recovered.

Optiray Side Effects Report #5062860-3
Optiray side effect was reported by a Physician from JAPAN on July 12, 2006. Female patient, 61 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea. Optiray dosage: 70 ML, SINGLE, INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #5106967-0
Optiray side effect was reported by a Physician from JAPAN on Aug 31, 2006. Female patient, 61 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea, oxygen saturation decreased. Optiray dosage: 70 ML, SINGLE, INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #4954573-0
Optiray side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Female patient, 61 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea. Optiray dosage: 70 ML, SINGLE, INTRAVENOUS. Patient recovered.


Optiray Side Effects Report #4978363-8
Optiray side effect was reported by a Physician from JAPAN on Apr 03, 2006. Female patient, 61 years of age, was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, depressed level of consciousness, dyspnoea, oxygen saturation decreased. Optiray dosage: 70 ML, SINGLE INTRAVENOUS. Patient recovered.

Optiray Side Effects Report #5824160-0
Optiray side effect was reported by a Physician from JAPAN on July 17, 2008. Female patient was diagnosed with computerised tomogram and was treated with Optiray. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardio-respiratory arrest, convulsion, depressed level of consciousness, nausea , pallor, pulse pressure decreased. Optiray dosage: 100 ML, SINGLE. Patient recovered.

Optiray Side Effects Report #5951545-4
Optiray side effect was reported by a Health Professional from JAPAN on Nov 06, 2008. Female patient was diagnosed with computerised tomogram, pain , osteoporosis  and was treated with Optiray. After drug was administered, patient experienced the following side effects: anaphylactic shock, blood pressure increased, depressed level of consciousness, dyspnoea, loss of consciousness. Optiray dosage: 67 ML, SINGLE. During the same period patient was treated with NEUROTROPIN, LOXOPROFEN, RISEDRONATE, ASPARTATE CALCIUM, ALFACALCIDOL. Patient recovered.